title: Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines.
authors.affiliation: Division of Infection and Immunity, University College London, London, UK; Department of Medical Microbiology, University College London Hospitals NHS Trust, London, UK.
authors.forename: Alimuddin I
authors.initials: AI
authors.lastname: Zumla
authors.affiliation: Henry M Jackson Foundation-Division of AIDS, TB Clinical Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Marco
authors.initials: M
authors.lastname: Schito
authors.affiliation: Therapeutic Immunology Division, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; CAST, Karolinska University Hospital, Stockholm SE-14186, Sweden. Electronic address: markus.maeurer@ki.se.
authors.forename: Markus
authors.initials: M
authors.lastname: Maeurer
mesh_terms: D015415:Biomarkers; D054908:Extensively Drug-Resistant Tuberculosis / Q000175:diagnosis*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D032581:Tuberculosis Vaccines; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control*
chemical_list: D015415:Biomarkers; D032581:Tuberculosis Vaccines